Clinical Trials Logo

Urinary Incontinence, Urge clinical trials

View clinical trials related to Urinary Incontinence, Urge.

Filter by:

NCT ID: NCT04031014 Recruiting - Overactive Bladder Clinical Trials

High Intensity Focused Electromagnetic Field Device for Urinary Incontinence

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

High intensity focused electromagnetic (HIFEM) technology induces deep pelvic floor muscle contractions designed to deliver the equivalent of 11,200 Kegel exercise over 28 minutes, with the intention of increasing neuromuscular tone of the pelvic floor. This study will have looking at treatment of the two of the most common pelvic floor disorders: stress or stress predominant urinary incontinence and urge or urge predominant urinary incontinence.

NCT ID: NCT03877640 Recruiting - Clinical trials for Stress Urinary Incontinence

Urinary Stress Incontinence and Urgency in Women With EMSELLA

Start date: January 11, 2019
Phase: N/A
Study type: Interventional

The purpose of this prospective study is to examine the safety and efficacy of high intensity focused electromagnetic (HIFEM) technology for the treatment of women with stress urinary incontinence (SUI), urge incontinence (UI) and mixed stress urinary and urge incontinence (MUI), looking at any potential sexual health benefits that may be concomitantly achieved from this treatment.

NCT ID: NCT03755089 Recruiting - Clinical trials for Urinary Incontinence

Oral vs Intravesical Analgesia for Office Bladder Botox Injections

OPIL
Start date: November 1, 2018
Phase: Phase 4
Study type: Interventional

OnabotulinumtoxinA (Botox®) bladder injections are a highly effective treatment for overactive bladder and urgency urinary incontinence. The procedure is typically performed in the office setting with one of two medications to control comfort. However, the effectiveness of these medications has never been compared. The goal of this study is to determine which medication is better at providing comfort during bladder Botox® injections.

NCT ID: NCT03742206 Recruiting - Overactive Bladder Clinical Trials

Comparison of Two Forms of Transcutaneous Electrical Stimulation in Overactive Bladder

Start date: January 25, 2018
Phase: N/A
Study type: Interventional

Aim: To compare the effects of parasacral transcutaneous electrical stimulation with transcutaneous posterior tibial nerve stimulation on the symptoms of Overactive Bladder in women. Study's hypothesis: The use of the parasacral transcutaneous electrical stimulation technique presents better results regarding the remission of overactive bladder symptoms in relation to transcutaneous posterior tibial nerve stimulation.

NCT ID: NCT03640364 Recruiting - Clinical trials for Urinary Urge Incontinence

Bilateral Sacrospinous Colposuspension (BSC) in the Female Genital Prolapse With Urinary Urge Symptomatology

Start date: April 1, 2018
Phase:
Study type: Observational

Prospective non-randomised trial investigating the effect of vaginal vault Suspension on urge symptomatology in female patients with pelvic organ prolapse

NCT ID: NCT03535857 Recruiting - Clinical trials for Overactive Bladder Syndrome

Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence

BUTTON
Start date: April 17, 2018
Phase: N/A
Study type: Interventional

This study is designed to evaluate whether bilateral Posterior Tibial Nerve Stimulation is more effective than unilateral Posterior Tibial Nerve Stimulation at treating overactive bladder and urge urinary incontinence

NCT ID: NCT02577302 Recruiting - Clinical trials for Urinary Incontinence, Urge

CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology

PROTECT
Start date: June 21, 2018
Phase: N/A
Study type: Interventional

This is a prospective, randomized, controlled, multi-center, study in which 150 evaluable subjects will be randomized 1:1 to receive either a Protect CAN-Stim or SNS InterStim® system. Subjects from both groups will immediately start with therapy. The primary endpoint is a ≥ 50% reduction in number of incontinence episodes associated with urgency at the 3-month visit, with additional measurements assessed at 14 days, 1, 6, 9 and 12-months.

NCT ID: NCT01737918 Recruiting - Clinical trials for Surgical Treatment of Urge Incontinence

Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa

URGE-II
Start date: January 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Urge urinary incontinence can be a disorder caused by destroyed pelvic structures. We repaired the uteri-sacral ligaments (USL) by cesa or vasa. The study evaluates if solifenacin can lead to continence after surgery or if also the pubo-urethral ligaments (PUL) need to be repaired.

NCT ID: NCT01737411 Recruiting - Clinical trials for Urge Urinary Incontinence

Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women

URGE-I
Start date: January 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if pelvic surgery can improve urge urinary incontinence in women more than standard medical treatment.

NCT ID: NCT00770406 Recruiting - Clinical trials for Urge Urinary Incontinence

Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence

Start date: January 2009
Phase: Phase 1/Phase 2
Study type: Interventional

A pilot study to examine efficacy and safety of intravesical botulinum toxin type A.